Evaluation of the effectiveness of sunscreens for photosensitive disorders

Atsushi Fukunaga, Chikako Nishigori, Kei Ito, Hiroshi Shimizu, Rikako Sasaki, Mayumi Kato, Yoshiki Miyachi, Satoshi Takeuchi, Akari Tashiro, Masutaka Furue

Research output: Contribution to journalArticle

Abstract

We tested 3 sunscreen products on 49 test subjects from May to December 2009. The subjects were patients suffering from photosensitivity and patients whose dermal conditions had worsened to erythematosus due to sunlight exposure; these patients had presented at 5 medical institutions. For our study, each of the patients was asked to use one or more of 3 sunscreen products, according to the severity of the required shielding, on an area of the body exposed to sunlight for a period of 4 weeks. The sunscreens were NOV® UV lotion EX, NOV® UV shield EX, and NOV® UV stick EX, products that do not contain ultraviolet light absorbing agents but contain micronized titanium dioxide as an ultraviolet light scattering agent. Two of the test subjects stopped using the sunscreen due to the development of erythema and pruritis at the site of application ; however, their cutaneous symptoms spontaneously improved a few days after the discontinuation. For the other 47 patients, who continued using the sunscreens, we obtained cutaneous assessments from their attending physician before and after the test. We then measured the level of oxidized protein and TNF-α, which were produced from the horny layer of the epidermis on exposure to ultraviolet light, by using the tape-stripping method, and verified a statistically significant difference between the results before and after the test. Furthermore, we carried out the same usage tests on 77 patients with conditions such as atopic dermatitis, for whom the avoidance of ultraviolet light is desirable for therapeutic reasons, and confirmed that the sunscreens are safe for these patients as well. Based on these results, we concluded that the 3 products examined in this study can be used safely by photosensitive patients and patients whose dermal condition worsens due to sunlight exposure, and that these products are highly effective sunscreens.

Original languageEnglish
Pages (from-to)271-277
Number of pages7
JournalNishinihon Journal of Dermatology
Volume73
Issue number3
DOIs
Publication statusPublished - Jan 1 2011

Fingerprint

Sunscreening Agents
Ultraviolet Rays
Sunlight
Skin
Atopic Dermatitis
Erythema
Pruritus
Epidermis
Physicians

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Evaluation of the effectiveness of sunscreens for photosensitive disorders. / Fukunaga, Atsushi; Nishigori, Chikako; Ito, Kei; Shimizu, Hiroshi; Sasaki, Rikako; Kato, Mayumi; Miyachi, Yoshiki; Takeuchi, Satoshi; Tashiro, Akari; Furue, Masutaka.

In: Nishinihon Journal of Dermatology, Vol. 73, No. 3, 01.01.2011, p. 271-277.

Research output: Contribution to journalArticle

Fukunaga, A, Nishigori, C, Ito, K, Shimizu, H, Sasaki, R, Kato, M, Miyachi, Y, Takeuchi, S, Tashiro, A & Furue, M 2011, 'Evaluation of the effectiveness of sunscreens for photosensitive disorders', Nishinihon Journal of Dermatology, vol. 73, no. 3, pp. 271-277. https://doi.org/10.2336/nishinihonhifu.73.271
Fukunaga, Atsushi ; Nishigori, Chikako ; Ito, Kei ; Shimizu, Hiroshi ; Sasaki, Rikako ; Kato, Mayumi ; Miyachi, Yoshiki ; Takeuchi, Satoshi ; Tashiro, Akari ; Furue, Masutaka. / Evaluation of the effectiveness of sunscreens for photosensitive disorders. In: Nishinihon Journal of Dermatology. 2011 ; Vol. 73, No. 3. pp. 271-277.
@article{da68aeaefc5d4c4c9d579882923629d8,
title = "Evaluation of the effectiveness of sunscreens for photosensitive disorders",
abstract = "We tested 3 sunscreen products on 49 test subjects from May to December 2009. The subjects were patients suffering from photosensitivity and patients whose dermal conditions had worsened to erythematosus due to sunlight exposure; these patients had presented at 5 medical institutions. For our study, each of the patients was asked to use one or more of 3 sunscreen products, according to the severity of the required shielding, on an area of the body exposed to sunlight for a period of 4 weeks. The sunscreens were NOV{\circledR} UV lotion EX, NOV{\circledR} UV shield EX, and NOV{\circledR} UV stick EX, products that do not contain ultraviolet light absorbing agents but contain micronized titanium dioxide as an ultraviolet light scattering agent. Two of the test subjects stopped using the sunscreen due to the development of erythema and pruritis at the site of application ; however, their cutaneous symptoms spontaneously improved a few days after the discontinuation. For the other 47 patients, who continued using the sunscreens, we obtained cutaneous assessments from their attending physician before and after the test. We then measured the level of oxidized protein and TNF-α, which were produced from the horny layer of the epidermis on exposure to ultraviolet light, by using the tape-stripping method, and verified a statistically significant difference between the results before and after the test. Furthermore, we carried out the same usage tests on 77 patients with conditions such as atopic dermatitis, for whom the avoidance of ultraviolet light is desirable for therapeutic reasons, and confirmed that the sunscreens are safe for these patients as well. Based on these results, we concluded that the 3 products examined in this study can be used safely by photosensitive patients and patients whose dermal condition worsens due to sunlight exposure, and that these products are highly effective sunscreens.",
author = "Atsushi Fukunaga and Chikako Nishigori and Kei Ito and Hiroshi Shimizu and Rikako Sasaki and Mayumi Kato and Yoshiki Miyachi and Satoshi Takeuchi and Akari Tashiro and Masutaka Furue",
year = "2011",
month = "1",
day = "1",
doi = "10.2336/nishinihonhifu.73.271",
language = "English",
volume = "73",
pages = "271--277",
journal = "Nishinihon Journal of Dermatology",
issn = "0386-9784",
publisher = "Kyushu University, Faculty of Science",
number = "3",

}

TY - JOUR

T1 - Evaluation of the effectiveness of sunscreens for photosensitive disorders

AU - Fukunaga, Atsushi

AU - Nishigori, Chikako

AU - Ito, Kei

AU - Shimizu, Hiroshi

AU - Sasaki, Rikako

AU - Kato, Mayumi

AU - Miyachi, Yoshiki

AU - Takeuchi, Satoshi

AU - Tashiro, Akari

AU - Furue, Masutaka

PY - 2011/1/1

Y1 - 2011/1/1

N2 - We tested 3 sunscreen products on 49 test subjects from May to December 2009. The subjects were patients suffering from photosensitivity and patients whose dermal conditions had worsened to erythematosus due to sunlight exposure; these patients had presented at 5 medical institutions. For our study, each of the patients was asked to use one or more of 3 sunscreen products, according to the severity of the required shielding, on an area of the body exposed to sunlight for a period of 4 weeks. The sunscreens were NOV® UV lotion EX, NOV® UV shield EX, and NOV® UV stick EX, products that do not contain ultraviolet light absorbing agents but contain micronized titanium dioxide as an ultraviolet light scattering agent. Two of the test subjects stopped using the sunscreen due to the development of erythema and pruritis at the site of application ; however, their cutaneous symptoms spontaneously improved a few days after the discontinuation. For the other 47 patients, who continued using the sunscreens, we obtained cutaneous assessments from their attending physician before and after the test. We then measured the level of oxidized protein and TNF-α, which were produced from the horny layer of the epidermis on exposure to ultraviolet light, by using the tape-stripping method, and verified a statistically significant difference between the results before and after the test. Furthermore, we carried out the same usage tests on 77 patients with conditions such as atopic dermatitis, for whom the avoidance of ultraviolet light is desirable for therapeutic reasons, and confirmed that the sunscreens are safe for these patients as well. Based on these results, we concluded that the 3 products examined in this study can be used safely by photosensitive patients and patients whose dermal condition worsens due to sunlight exposure, and that these products are highly effective sunscreens.

AB - We tested 3 sunscreen products on 49 test subjects from May to December 2009. The subjects were patients suffering from photosensitivity and patients whose dermal conditions had worsened to erythematosus due to sunlight exposure; these patients had presented at 5 medical institutions. For our study, each of the patients was asked to use one or more of 3 sunscreen products, according to the severity of the required shielding, on an area of the body exposed to sunlight for a period of 4 weeks. The sunscreens were NOV® UV lotion EX, NOV® UV shield EX, and NOV® UV stick EX, products that do not contain ultraviolet light absorbing agents but contain micronized titanium dioxide as an ultraviolet light scattering agent. Two of the test subjects stopped using the sunscreen due to the development of erythema and pruritis at the site of application ; however, their cutaneous symptoms spontaneously improved a few days after the discontinuation. For the other 47 patients, who continued using the sunscreens, we obtained cutaneous assessments from their attending physician before and after the test. We then measured the level of oxidized protein and TNF-α, which were produced from the horny layer of the epidermis on exposure to ultraviolet light, by using the tape-stripping method, and verified a statistically significant difference between the results before and after the test. Furthermore, we carried out the same usage tests on 77 patients with conditions such as atopic dermatitis, for whom the avoidance of ultraviolet light is desirable for therapeutic reasons, and confirmed that the sunscreens are safe for these patients as well. Based on these results, we concluded that the 3 products examined in this study can be used safely by photosensitive patients and patients whose dermal condition worsens due to sunlight exposure, and that these products are highly effective sunscreens.

UR - http://www.scopus.com/inward/record.url?scp=79960827140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960827140&partnerID=8YFLogxK

U2 - 10.2336/nishinihonhifu.73.271

DO - 10.2336/nishinihonhifu.73.271

M3 - Article

VL - 73

SP - 271

EP - 277

JO - Nishinihon Journal of Dermatology

JF - Nishinihon Journal of Dermatology

SN - 0386-9784

IS - 3

ER -